AKAN - AKANDA CORP.

3.4201
-0.120   -3.506%

Share volume: 65,875
Last Updated: 04-20-2026
Pharmaceutical Products/Medicinal Chemicals: -0.15%

PREVIOUS CLOSE
CHG
CHG%
$3.54
-0.12
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
93%
Profitability 100%
Dept financing 50%
Liquidity 75%
Performance 100%
Performance
5 Days
3.95%
1 Month
309.54%
3 Months
137.51%
6 Months
55.46%
1 Year
192.32%
2 Year
3,646.00%
Key data
Stock price
$3.42
P/E Ratio 
0.00
DAY RANGE
$3.22 - $3.57
EPS 
N/A
52 WEEK RANGE
$0.42 - $9.29
52 WEEK CHANGE
$194.84
MARKET CAP 
15.256 M
YIELD 
N/A
SHARES OUTSTANDING 
11.930 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
3.75
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$79,550
AVERAGE 30 VOLUME 
$402,978
Company detail
CEO: Tejinder Virk
Region: US
Website: akandacorp.com
Employees: 110
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Akanda Corp. engages in the cultivation, manufacture, and distribution of cannabis products. It intends to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Recent news